Objective: To determine the effect of aromatherapy on anxiety and depression in patients with Khdvs Astv cardiac ICU study design: randomized, single-blind, placebo-controlled, phase 2 clinical trial Study population: patients admitted to the cardiac intensive care unit standards Help with anxiety and depression over 7-based tools HADS, age ≥ 18 years, patients with a diagnosis of ischemic heart disease, angina and myocardial infarction, non-allergic to flowers and plants or any allergy season Exclusion criteria: Cancel the patient continued study to heart failure and grade 3 or 4, discharge, death or transfer of the patient prior to the completion of the study, creating a situation of stress new interventions: a period of two days, starting at 11 am, use 2 drops of essential oil of Lavender along collar, Filled out questionnaires assessing anxiety and DEPRESION before the intervention, an hour later, 9 hours after the intervention period:
Beginning in January 1391
the first case of primary outcome: length of hospital stay in patients' levels of anxiety and depression in